Literature DB >> 7539579

Multiple false reactions in viral antibody screening assays after influenza vaccination.

L Simonsen1, J Buffington, C N Shapiro, R C Holman, T W Strine, B J Grossman, A E Williams, L B Schonberger.   

Abstract

In December 1991, US blood centers reported an unusual increase in donations that tested falsely reactive for antibodies to two or more (multiple false positive) of the following viruses: human immunodeficiency virus type 1 (HIV-1), human T-cell lymphotrophic virus type I (HTLV-I), and hepatitis C virus. Many of these donations were from people who had recently received the 1991-1992 influenza vaccine, raising the possibility that this vaccine had somehow specifically caused the problem of multiple false reactivity. A case-control study of 101 affected donors and 191 matched controls found that recent receipt of any brand of influenza vaccine was significantly associated with testing multiple false positive (p < 0.05), as was a history of recent acute illness (p < 0.05) and of allergies (p < 0.05). Surveillance for monthly rates of multiple reactive donations from May 1990 through December 1992 linked the seasonal cluster of multiple false-positive donations to the use of viral screening test kits thought to react nonspecifically to donor immunoglobulin M. There was no similar increase in multiple false-positive donations during the 1992-1993 influenza vaccination season after the HIV-1 and hepatitis C virus tests were replaced; however, the number of donations that were falsely reactive for only HTLV-I almost doubled, indicating that false reactivity was not specifically associated with the 1991-1992 influenza vaccine. Retesting of affected donors found that the duration of HTLV-I and hepatitis C virus false reactivity was 3-6 months. The cluster of multiple false-positive donations in 1991 was most likely caused by the test kits used, rather than by the influenza vaccine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539579     DOI: 10.1093/oxfordjournals.aje.a117374

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  5 in total

1.  Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients.

Authors:  Cristine J Cooper; Barbara Metch; Joan Dragavon; Robert W Coombs; Lindsey R Baden
Journal:  JAMA       Date:  2010-07-21       Impact factor: 56.272

2.  Epidemiological and molecular profile of blood donors infected with HTLV-1/2 in the state of Pará, northern Brazil.

Authors:  Carolina de Alcantara Maneschy; Katarine Antonia Dos Santos Barile; Jairo Augusto Américo de Castro; Maurício Koury Palmeira; Renata Bezerra Hermes de Castro; Carlos Eduardo de Melo Amaral
Journal:  Braz J Microbiol       Date:  2021-09-09       Impact factor: 2.214

3.  Seroindeterminate HTLV-1 prevalence and characteristics in blood donors in Taiwan.

Authors:  Shih Chien Lu; Bai Hsiun Chen
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

4.  Prospective study of the meaning of indeterminate results of the recombinant immunoblot assay for hepatitis C virus in blood donors.

Authors:  Loredana Piro; Stefano Solinas; Marina Luciani; Andrea Casale; Tiziana Bighiani; Daniela Santonocito; Gabriella Girelli
Journal:  Blood Transfus       Date:  2008-04       Impact factor: 3.443

5.  Risk factors associated with false positive HIV test results in a low-risk urban obstetric population.

Authors:  Tamara T Chao; Jeanne S Sheffield; George D Wendel; M Qasim Ansari; Donald D McIntire; Scott W Roberts
Journal:  J Pregnancy       Date:  2011-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.